Medical Device Cleaning Market (2025-2034)

How Large Is the Medical Device Cleaning Market and What Is Fueling Its Expansion?

The Global Medical Device Cleaning Market was valued at USD 7.20 billion in 2025 and is projected to reach USD 13.57 billion by 2034, expanding at a 7.3% CAGR. The market covers detergents, enzymatic cleaners, cleaning equipment, automated washers, endoscope reprocessors, accessories, testing products, and workflow systems used to prepare reusable devices for disinfection or sterilization. Demand is increasing because reusable surgical instruments cannot move safely into later reprocessing stages until soils are removed. CDC guidance specifically requires meticulous cleaning before high-level disinfection or sterilization.

The operational base is substantial. HSPA recorded 54,525 current CRCST certifications and 4,773 current CER certifications at the end of 2025, showing a sizeable professional workforce around sterile processing and endoscope workflows. Procedure intensity adds another layer: more than 17.7 million GI endoscopic procedures are performed annually in the U.S., while more than 500,000 bronchoscopies are conducted each year, creating repeated cleaning demand rather than one-time procurement.

Key Report Takeaways for the Medical Device Cleaning Market

• In product type, cleaning agents remain dominant at 43.8% of the 2025 market, worth about USD 3.15 billion, while cleaning equipment is the fastest-growing component at a 9.3% CAGR and already represents 37.6% or USD 2.71 billion.
• Manual cleaning continues to account for the larger method share at 57.2%, equivalent to USD 4.12 billion in 2025, whereas automated cleaning is advancing faster at a 9.5% CAGR from a 42.8% share.
• Surgical instruments lead device applications with a 43.5% share and approximately USD 3.13 billion in 2025, but endoscopes are expanding fastest at an estimated 8.6% CAGR and command a 24.5% share.
• Hospitals and clinics generated the dominant 63.4% share, or nearly USD 4.56 billion, in 2025; ambulatory surgical centers are the quickest-growing end-user group at a 9.4% CAGR with a 16.8% share.

Why Regulatory Validation Is Reshaping the Medical Device Cleaning Market

Regulation is not a side issue in medical device cleaning. It directly determines what can be sold, how devices are processed, and how manufacturers write their instructions. In the U.S., FDA guidance requires reprocessing validation for certain reusable-device submissions, including cleaning validation, with bronchoscopes specifically identified among higher-risk products requiring validation data in applicable 510(k) submissions. CDC recommendations further establish cleaning with water and detergent or enzymatic products before high-level disinfection or sterilization.

Globally, ISO 17664-1:2021 requires manufacturers of critical and semi-critical reusable devices to provide processing information covering cleaning, disinfection, drying, inspection, maintenance, sterilization, storage, and transport. ISO/TS 17664-3:2026 goes further by introducing guidance for classifying reusable devices according to cleaning requirements and supporting cleaning validation. In the U.S., ANSI/AAMI ST91:2021 governs flexible and semi-rigid endoscope processing, while ST79 remains a core reference for steam sterilization and sterile-processing practice.

How Product Mix Is Shifting in the Medical Device Cleaning Market

Cleaning agents held an estimated 43.8% share of the medical device cleaning market in 2025, translating to USD 3.15 billion, with a 6.6% CAGR through 2034. Their dominance comes from repeat consumption: enzymatic and specialized detergents are required across routine instrument turnover, manual sink processing, ultrasonic cleaning, and automated washer cycles. The recurring nature of the category is commercially important because cleaning chemistry moves with every processing cycle. For example, STERIS supplies Prolystica and Revital-Ox chemistry alongside its washer and endoscope reprocessing systems, while Borer Chemie positions deconex products across medical-device cleaning and disinfection workflows.

Cleaning equipment is the fastest-growing product category, rising at an estimated 9.3% CAGR to a projected 2034 value of USD 6.24 billion from a 2025 base of USD 2.71 billion. Its 37.6% starting share is expanding as hospitals address staff shortages, throughput bottlenecks, water-use efficiency and process standardization. Providers such as Getinge, SteelcoBelimed and Miele compete through washer-disinfectors and integrated sterile-processing systems rather than standalone machines, making automation part of a broader workflow investment. Getinge explicitly positions sterile reprocessing around controlled workflow and throughput, while SteelcoBelimed markets integrated cleaning, disinfection and sterilization solutions.

Why Automated Processing Is Gaining Ground in the Medical Device Cleaning Market

Manual cleaning represented approximately 57.2% of the 2025 market, or USD 4.12 billion, and is advancing at a more measured 5.8% CAGR. It remains unavoidable because brushing, flushing, leak testing and visual inspection frequently precede automated processing, particularly for complex or delicate devices. CDC guidance confirms that manual cleaning remains necessary where mechanical units are unavailable or for fragile and difficult-to-clean instruments. For example, STERIS maintains manual endoscope detergents, sponges and leak-testing equipment, while Ruhof serves the market with specialized cleaning chemistry and endoscope-focused processing products.

Automated cleaning is advancing at an estimated 9.5% CAGR and held a 42.8% share worth about USD 3.08 billion in 2025. Labor pressure is only part of the reason. Consistent cycle parameters, traceability, controlled chemistry dosing and lower dependence on operator variation are increasingly valuable. Early innovation includes automated endoscope reprocessing platforms that connect physical cleaning with documentation. Wassenburg, for instance, combines washer-disinfectors, drying cabinets, process chemicals and traceability software, while Getinge offers automated endoscope reprocessing configured for high-throughput departments.

Where Device-Specific Cleaning Demand Is Concentrating in the Medical Device Cleaning Market

Surgical instruments remained the largest application with an estimated 43.5% share, equivalent to USD 3.13 billion in 2025, and are projected to grow at a 6.7% CAGR. Their lead is straightforward: procedure volumes create continuous turnover across large instrument inventories, and hospital sterile processing departments need predictable throughput between operating cases. Firms such as STERIS, Getinge and SteelcoBelimed have built broad washer, ultrasonic-cleaning and workflow portfolios around these high-volume instrument cycles.

Endoscopes are the fastest-growing device application at an estimated 8.6% CAGR, reaching approximately USD 4.00 billion by 2034 from USD 1.76 billion in 2025. The higher growth rate reflects the difficulty of processing long internal channels, the consequences of residual bioburden, and the expanding volume of minimally invasive procedures. More than 17.7 million GI endoscopic procedures are performed annually in the U.S., creating an exceptionally large recurring processing workload. For example, Olympus operates automated endoscope reprocessing solutions, while Wassenburg provides washers, drying and storage, consumables and traceability across the endoscope cycle. 

Why Hospitals Still Dominate the Medical Device Cleaning Market While ASCs Accelerate

Hospitals and clinics accounted for an estimated 63.4% of demand in 2025, or USD 4.56 billion, growing at a 6.5% CAGR. Their lead reflects sheer processing volume, larger sterile-processing departments and broader inventories of reusable surgical devices. The business model is reinforced by long replacement cycles for capital equipment and continuous spending on chemicals, accessories, maintenance and validation. STERIS explicitly combines sterile-processing equipment, surgical cleaning chemistries, endoscope reprocessing, repair and maintenance services in its healthcare portfolio, illustrating how hospital demand supports multiple revenue streams.

Ambulatory surgical centers are the fastest-growing end-user group at an estimated 9.4% CAGR, with a 16.8% share worth USD 1.21 billion in 2025. Outpatient procedures are pushing cleaning requirements closer to compact, efficient and space-conscious systems, especially where staffing is limited. For example, SteelcoBelimed and Tuttnauer serve facilities looking for smaller-footprint automated processing options, while STERIS offers washer systems designed for both SPDs and ASCs.

How Regional Procurement Is Recasting the Medical Device Cleaning Market

North America accounted for an estimated 31.7% of the medical device cleaning market in 2025, worth USD 2.28 billion, and is expected to grow at a 6.4% CAGR. The region retains its lead because hospitals have mature sterile-processing infrastructure, established compliance programs and high procedure volumes. U.S. demand is particularly supported by endoscopy and surgical throughput: more than 17.7 million GI endoscopic procedures are conducted annually, while bronchoscopies add another high-volume reprocessing workload. For example, STERIS continues to expand washer, chemistry and endoscope reprocessing offerings, while Censis adds digital endoscope traceability through ScopeTrac Advanced, bringing process documentation into the reprocessing workflow.

Europe held an estimated 27.1% share, equivalent to USD 1.95 billion in 2025, and is projected to advance at a 6.8% CAGR. Demand is being reinforced by tighter documentation, device-processing requirements and modernization of sterile-processing departments. The region also benefits from a strong manufacturing base in specialist reprocessing equipment and cleaning chemistry. For instance, Getinge continues to invest across sterile reprocessing while Wassenburg combines equipment, chemicals and traceability into an integrated endoscope workflow. 

Asia Pacific represented about 25.8% of the market in 2025, corresponding to USD 1.86 billion, but is the fastest-expanding region at an estimated 9.1% CAGR. Growth is tied to new hospital construction, improving infection-control practices, rising procedural volumes and migration from labor-intensive manual workflows toward automated systems. Japan, China, South Korea and India are driving much of the addressable opportunity, with demand increasingly shifting from basic consumables toward integrated equipment.

Latin America captured an estimated 8.4% share, or USD 0.60 billion, in 2025, and should expand at roughly 7.4% CAGR. Demand is rising as private hospitals and larger surgical centers modernize sterile-processing infrastructure, although capital affordability still limits penetration of premium automation. Regional procurement tends to favor equipment that can combine reasonable throughput with simpler servicing and consumable availability.

The Middle East and Africa accounted for about 7.0%, or USD 0.50 billion, in 2025 and is forecast to grow at approximately 6.9% CAGR. Demand is being lifted by hospital expansion, medical-tourism infrastructure and infection-prevention investment, particularly in Gulf healthcare systems. The opportunity is strongest where centralized sterile-processing departments are being built alongside new tertiary and specialist hospitals.

Competitive Positioning Across the Medical Device Cleaning Market

The competitive structure is broader than the handful of firms usually placed on the front page of a market report. The market includes integrated sterile-processing OEMs, specialist endoscope companies, chemistry manufacturers, ultrasound-probe disinfection specialists, workflow software providers, and regional washer-disinfector manufacturers. Current industry coverage identifies companies including STERIS, Getinge, Belimed, Steelco, Miele, MMM, Matachana, Tuttnauer, Smeg Instruments, Shinva, CISA, AT-OS, DEKO MedTech, Wassenburg, Olympus, Ecolab, Nanosonics, Tristel, Ruhof, Borer Chemie, Oro Clean Chemie, Metrex, Case Medical, SciCan, Ken Hygiene Systems, Skytron, Laoken, Medivators, Censis and others across the broader device-cleaning and reprocessing ecosystem. 

STERIS

STERIS has one of the broadest portfolios in the market, spanning washer-disinfectors, ultrasonic cleaning equipment, decontamination sinks, surgical instrument cleaning chemistries, automated endoscope reprocessors, high-level disinfectants, transport and storage systems, repair and maintenance, and digital workflow solutions. Its strength is the ability to sell the equipment and then remain embedded in the customer's recurring operating workflow.

Getinge

Getinge competes through integrated sterile-processing infrastructure, including washer-disinfectors, automated endoscope reprocessors and broader sterile reprocessing workflow solutions. Its portfolio is particularly suited to hospitals seeking connected, high-capacity systems rather than isolated pieces of equipment.

SteelcoBelimed

SteelcoBelimed combines the Steelco and Belimed capabilities into a broad cleaning, disinfection and sterilization platform. Its portfolio covers medical-device washers, disinfection systems, workflow components and integrated sterile-processing solutions for healthcare environments. 

Olympus

Olympus has a particularly strong position in endoscope-centered reprocessing, combining endoscopy systems with hygiene and reprocessing equipment, service contracts and outsourced reprocessing support. Its Sapphire facility in Australia also demonstrates the move toward centralized service-led reprocessing models. 

Wassenburg Medical

Wassenburg focuses heavily on flexible endoscope reprocessing, with washer-disinfectors, drying and storage cabinets, dedicated process chemicals, transport systems, traceability software, training, maintenance and validation. This makes it one of the clearest end-to-end specialists in the niche. 

Ecolab

Ecolab competes primarily through healthcare infection-prevention and cleaning chemistry, giving hospitals access to detergents, disinfectants and broader hygiene-management solutions. Its strategic relevance is strongest where chemical performance and recurring supply contracts influence procurement.

Miele Professional

Miele Professional is positioned around washer-disinfectors and automated instrument-processing equipment, particularly compact and mid-capacity systems suited to hospitals, clinics and specialized healthcare facilities. Its product strategy places emphasis on repeatable automated processing rather than manual handling.

Tristel

Tristel is a specialist infection-prevention company with a strong position in high-level disinfection technologies, particularly for devices that require rapid point-of-care or local reprocessing. Its niche positioning allows it to compete where conventional centralized systems are impractical.

Nanosonics

Nanosonics operates in a more specialized corner of the market with automated high-level disinfection for ultrasound probes. Its trophon platform combines HLD with traceability features, making it relevant to the growing demand for standardized point-of-care reprocessing of ultrasound equipment.

Censis

Censis adds the software layer to reprocessing. Its ScopeTrac Advanced platform tracks endoscopes from point of use through storage, records reprocessing events, supports workflow enforcement and generates compliance documentation. The value proposition is not cleaning chemistry itself, but proving that the cleaning process happened correctly and consistently.

The commercial signal across these competitors is clear: the market is gradually moving away from selling a cleaner or a machine as an isolated product. Winning portfolios increasingly connect chemistry, equipment, validation, maintenance, traceability and training into one recurring workflow. That is where the stronger margins and customer retention are likely to sit. STERIS's healthcare model, the integrated approach of Wassenburg and the digital layer provided by Censis all point in the same direction.